Document Detail

Expression level of novel tumor suppressor gene FATS is associated with the outcome of node positive breast cancer.
MedLine Citation:
PMID:  22040499     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Recently, we reported the identification of a previously uncharacterized and evolutionarily conserved gene, fragile-site associated tumor suppressor (FATS), at a frequently deleted region in irradiation (IR)-induced tumors. However, the role of FATS in breast cancer development and its clinical significance has not been defined. The aim of this study was to determine the role of FATS in breast cancer development and to evaluate its clinical significance in breast cancer.
METHODS: The expression level of FATS mRNA was determined in 106 breast carcinomas and 23 paired normal breast tissues using quantitative real time reverse transcription-polymerase chain reaction (RT-PCR). The relationship between FATS expression and clinicopathological parameters were also analyzed.
RESULTS: The mRNA level of FATS was down-regulated in breast cancer compared with paired normal tissues. Low expression of FATS was correlated with high nuclear grade. There was a tendency to a favorable outcome for patients with high expression of FATS (P = 0.346). However, low expression of FATS was associated with poor outcome of breast cancer patients with node positive (P = 0.011). Furthermore, the mRNA level of FATS showed an independent value in predicting the outcome of breast cancer patients with positive lymph nodes.
CONCLUSION: FATS is involved in the carcinogenesis and development of breast cancer and could be a potential biomarker and prognostic factor for breast cancer therapy.
Jun Zhang; Lin Gu; Lu-Jun Zhao; Xi-Feng Zhang; Li Qiu; Zheng Li
Related Documents :
212839 - Prospects of vaccines against cancer in man.
21691749 - Elevated expression of usp22 in correlation with poor prognosis in patients with invasi...
22065479 - Influence of uncommon histology on breast conservation therapy for breast cancer-biolog...
3956439 - The 'safety snare'--a ligature-placing snare to prevent haemorrhage after transection o...
18288999 - Chemoprevention of cancer by isothiocyanates and anthocyanins: mechanisms of action and...
21845209 - Disease extent ≥4 cm is a prognostic marker of local recurrence in t1-2 breast cancer.
23266799 - Association of glutamate carboxypeptidase ii (gcpii) haplotypes with breast and prostat...
2757559 - Clinical and histopathological considerations for the diagnosis and treatment of verruc...
20427049 - Metastasis of canine inflammatory versus non-inflammatory mammary tumours.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Chinese medical journal     Volume:  124     ISSN:  0366-6999     ISO Abbreviation:  Chin. Med. J.     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-11-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7513795     Medline TA:  Chin Med J (Engl)     Country:  China    
Other Details:
Languages:  eng     Pagination:  2894-8     Citation Subset:  IM    
Department of Biochemistry and Molecular Biology, Key Laboratory of Ministry of Education for Breast Cancer Prevention and Treatment, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Visualization of Medpor implants using surface rendering.
Next Document:  Molecular mechanism of icariin on rat asthmatic model.